Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.

Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L, Hadley K, Sundblad A, Sjoberg J, Bjorkholm M, Porwit AA, Yap LF, Teo S, Grundy RG, Young LS, Ernberg I, Woodman CB, Murray PG.

Am J Pathol. 2008 Jul;173(1):195-204. doi: 10.2353/ajpath.2008.070845. Epub 2008 May 23.

2.

Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.

Assis MC, Campos AH, Oliveira JS, Soares FA, Silva JM, Silva PB, Penna AD, Souza EM, Baiocchi OC.

Med Oncol. 2012 Dec;29(5):3614-9. doi: 10.1007/s12032-012-0299-4. Epub 2012 Jul 13.

PMID:
22791223
3.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
4.

Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.

Morales O, Mrizak D, François V, Mustapha R, Miroux C, Depil S, Decouvelaere AV, Lionne-Huyghe P, Auriault C, de Launoit Y, Pancré V, Delhem N.

Br J Haematol. 2014 Sep;166(6):875-90. doi: 10.1111/bjh.12980. Epub 2014 Jul 9.

PMID:
25041527
5.

Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.

Pavlovic A, Glavina Durdov M, Capkun V, Jakelic Pitesa J, Bozic Sakic M.

Med Sci Monit. 2016 Jul 5;22:2340-6.

6.

A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

Rajnavölgyi E, Nagy N, Thuresson B, Dosztányi Z, Simon A, Simon I, Karr RW, Ernberg I, Klein E, Falk KI.

Int Immunol. 2000 Mar;12(3):281-93.

PMID:
10700463
7.

Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.

Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.

Cancer Sci. 2008 Aug;99(8):1633-42. doi: 10.1111/j.1349-7006.2008.00852.x.

8.

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.

Adhikary D, Behrends U, Boerschmann H, Pfünder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J.

PLoS One. 2007 Jul 4;2(7):e583. Review.

9.

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

Gandhi MK, Lambley E, Duraiswamy J, Dua U, Smith C, Elliott S, Gill D, Marlton P, Seymour J, Khanna R.

Blood. 2006 Oct 1;108(7):2280-9. Epub 2006 Jun 6.

10.
11.

Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.

Hayashi T, Yamabe H, Haga H, Akasaka T, Kadowaki N, Ohno H, Okuma M, Fukuhara S.

Int J Hematol. 1995 Jun;61(4):215-22.

PMID:
8547610
12.

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW.

Blood. 2002 Jan 15;99(2):618-26.

13.

Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus.

Siebert JD, Ambinder RF, Napoli VM, Quintanilla-Martinez L, Banks PM, Gulley ML.

Hum Pathol. 1995 Nov;26(11):1191-5.

PMID:
7590691
14.

Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.

Flavell JR, Baumforth KR, Wood VH, Davies GL, Wei W, Reynolds GM, Morgan S, Boyce A, Kelly GL, Young LS, Murray PG.

Blood. 2008 Jan 1;111(1):292-301. Epub 2007 Aug 24.

16.

Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.

Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.

Cancer Res. 1995 Aug 15;55(16):3675-81.

17.

Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.

Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A.

Immunology. 2006 Mar;117(3):379-85.

18.

[Epstein-Barr virus presence in Colombian Hodgkin lymphoma cases and its relation to treatment response].

Quijano S, Saavedra C, Fiorentino S, Orozco O, Bravo MM.

Biomedica. 2004 Jun;24(2):163-73. Spanish.

PMID:
15495596
20.

Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.

Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM.

J Med Virol. 2002 Nov;68(3):370-7.

PMID:
12226824

Supplemental Content

Support Center